Review of prescription medications in home-based older adults with stroke: A pilot study

Research in Social and Administrative Pharmacy

Volumn 3, Issue 1, 2007, Pages 104-122

  Classen, Sherrilene ^a   Meuleman, John ^b,c   Garvan, Cynthia ^b   Ried, L Douglas ^c   Mann, William ^a   Asal, Nabih ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cross sectional and longitudinal analysis; Drug drug interactions; Geriatric medications; Inappropriately prescribed drugs; Polypharmacy

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG INTERACTION; DRUG USE; FEMALE; HEART DISEASE; HOME CARE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PILOT STUDY; POLYPHARMACY; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; FEMALE; FLORIDA; HEART DISEASES; HOME CARE SERVICES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; POLYPHARMACY; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33847679392     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.06.002     Document Type: Article

References (40)

1. The U.S. Administration on Aging. Facts and figures: statistics on minority aging in the U.S. Available at:. http://www.aoa.gov/prof/Statistics/minority_aging Accessed 02.05.04
2. National Vital Statistics. Leading causes of death among persons age 65 or older by sex, and race, and Hispanic origin, 1997. Available at:. http://www.aoa.gov/prof/Statistics/minority_aging/facts_minority_aging.asp#LeadingCauseofDeath Accessed 03.05.03
3. American Heart Association. Heart disease and stroke statistics update. Available at:. http://www.americanheart.org/presenter.jhtml?identifier=1928 Accessed 04.04.04
4. American Stroke Association. About Stroke. Available at:. http://www.strokeassociation.org/presenter.jhtml?identifier=11402 Accessed 18.04.04
5. Schwarze M. Selecting therapy for elderly at risk for coronary heart disease or stroke. Clinical Geriatrics. Available at: http://www.mmhc.com/engine.pl?station=mmhc&template=cgfull.html&id=1027. Accessed 18.04.04.
6. The Internet Stroke Center. Stroke treatment. Available at: (2002). http://www.strokecenter.org/pat/tpa Accessed 10.04.04
7. Carlson J.E. Perils of polypharmacy: 10 steps to prudent prescribing. Geriatrics 51 (1996) 26-31
8. Veehof L.J., Stewart R., Haaier-Ruskamp F.M., and Meyboom deJong B. Chronic polypharmacy in one third of the elderly in family practice. Ned Tijdschr Geneeskd 143 (1999) 93-97
9. Williams C.M. Using medications appropriately in older adults. Am Fam Physician 66 (2002) 1917-2005
10. Cadieux R.J. Drug interactions in the elderly: how multiple drug use increases risks exponentially?. Postgrad Med 86 (1989) 179-186
11. Cipolle R.J., Strand L.M., and Morley P.C. Pharmaceutical Care Practice (1998), McGraw Hill, New York
12. Gallagher L.P. The potential for adverse drug reactions in elderly patients. Appl Nurs Res 14 (2001) 220-224
13. Graziano O., Pendone C., Landi F., et al. Adverse drug reactions as cause of hospital admissions: results from the Italian group pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 50 (2002) 1962-1968
14. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly, an update. Arch Intern Med 157 (1997) 1531-1536
15. Beers M.H., Ouslander J.G., Rollinger I., Reuben D., Brooks J., and Beck J.C. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 151 (1991) 1825-1832
16. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean R., and Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163 (2003) 2716-2724
17. Hanlon J.T., Fillenbaum G.G., Kuchibhatla M., et al. Impact of inappropriately prescribed drugs on mortality and functional status in representative community dwelling elders. Med Care 40 (2002) 166-176
18. McLeod J.P., Huang A.R., and Tamblyn R.M. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 156 (1997) 385-391
19. Hanlon J.T., Schmader K.E., and Boult C. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 50 (2002) 26-34
20. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., and Mitchell A.A. Recent patterns of medication use in the ambulatory population of the United States: the Sloane survey. JAMA 287 (2002) 337-344
21. Morley J.E. Drugs, aging and the future. J Gerontol A Biol Sci Med Sci 574A (2002) M2-M6
22. Fick D.M., Waller J.L., and Maclean J.R. Potentially inappropriate medication use in a managed care population: association with higher cost and utilization. J Manag Care Pharm 7 (2001) 407-413
23. National Center for Health Statistics. Elderly patients prescribed inappropriate medications at 8 percent of doctor's visits. Available at:. http://www.cdc.gov/nchs/pressroom/04news/elderly.htm Accessed 30.05.04
24. Hammerlein A., Derendorf H., and Lowenthal D.T. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 35 (1998) 49-64
25. Merck Manual of Diagnosis and Therapy. Clinical Pharmacology: Drug therapy in the elderly. Available at: http://www.merck.com/mrkshared/mmanual/section22/chapter304/304d.jsp. Accessed 20.08.04.
26. Wehinger C., Stöllberger C., Länger T., Scheneider B., and Finsterer J. Evaluation of risk factors for stroke/embolism and of complications due to anticoagulant therapy in atrial fibrillation. Stroke 32 (2001) 2246-2252
27. Quilliam B.J., Lapane K.L., Eaton C.B., and Mor V. Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors. Stroke 32 (2001) 2299-2304
28. Alfaro C.L. Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown. Psychopharmacol Bull 35 (2001) 80-93
29. In: Hansten P.D., and Horn J.R. (Eds). Hansten and Horn's Managing Clinically Important Drug Interactions. 4th ed. (2004), Facts & Comparisons, St Louis, MO
30. Carswell J.L., Beard K.A., Chevrette M.M., Pardue C.N., Hess D.C., and Fagan S.C. Tracking trends in secondary stroke prevention strategies. Ann Pharmacother 38 (2004) 215-219
31. Chobanian A.V., Bakris G.L., Black H.R., et al. JNC-complete version: seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
32. Perry D., and Webster R. Medication-related problems in aging: implications for professionals and policy makers. Generations 24 (2000/2001) 28-36
33. Bootman J.L., Harrison D.L., and Cox G. The healthcare cost and drug related mortality and morbidity in nursing facilities. Arch Intern Med 157 (1997) 2089-2096
34. Johnson J.A., and Bootman J.L. Drug related morbidity and mortality: a cost-of-illness model. Arch Intern Med 155 (1995) 1949-1956
35. Mann W., Karuza J., Hurren D., and Tomita M. Needs of home-based older persons for assistive devices: The University at Buffalo Rehabilitation Engineering Center on Aging Consumer Assessments Study. Technol Disabil 2 (1993) 1-11
36. Clinical Pharmacology 2000, Copyright 2004 Gold Standard. Available at:. http://cpip.gsm.com/ Accessed 20.08.04
37. American Society of Health Systems Pharmacists. Snapshot of medication use in the U.S. American Society of Health Systems Pharmacists Research Report. December 2000.
38. Ebrahim S., and Harwood R. Stroke: Epidemiology, Evidence, and Clinical Practice. 2nd ed. (1999), Oxford University Press, New York
39. Murray V., von Arbin M., Bartfai A., et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 66 (2005) 708-716
40. Choi-Kwon S., Han Sung W., Kwon Sun U., et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness, a double blind, placebo-controlled study. Stroke 37 (2006) 156-161